MBRX · Moleculin Biotech, Inc. · Fails to Deliver
$7.74
-0.19 (-2.40%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2025 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Nov 13, 2026
Market Cap
$8.22M
Shares
1.06M
Volume · Nov 20
49.56K
Avg daily vol (24 sessions)
44.57K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 1,234 | $8.72 | $10,760 |
| 2026-10-29 | 41 | $8.75 | $359 |
| 2026-10-28 | 19 | $9.27 | $176 |
| 2026-10-26 | 1,485 | $6.50 | $9,653 |
| 2026-10-23 | 4 | $5.89 | $24 |
| 2026-10-22 | 6 | $6.31 | $38 |
| 2026-10-21 | 10,526 | $6.19 | $65,156 |
| 2026-10-19 | 9,345 | $0.28 | $2,617 |
| 2026-10-13 | 1,130 | $0.41 | $463 |
| 2026-10-02 | 12,634 | $0.50 | $6,317 |
| 2026-09-24 | 5,132 | $0.53 | $2,720 |
| 2026-09-23 | 49,019 | $0.57 | $27,941 |
| 2026-09-17 | 40 | $0.74 | $30 |
| 2026-09-10 | 10 | $0.77 | $8 |
| 2026-09-08 | 86 | $0.71 | $61 |
| 2026-09-04 | 83 | $0.68 | $56 |
| 2026-09-03 | 646 | $0.69 | $446 |
| 2026-09-02 | 663 | $0.65 | $431 |
| 2026-09-01 | 319 | $0.64 | $204 |
| 2026-08-31 | 513 | $0.65 | $333 |
| 2026-08-28 | 571 | $0.69 | $394 |
| 2026-08-26 | 44,846 | $0.61 | $27,356 |
Showing 1–22 of 22 settlements
Key facts
CIK
1659617
CUSIP
60855D507
13F (30d)
32 filings
22 filers
Visit website
Investor relations